Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Compass Therapeutics (CMPX) Return on Equity (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Return on Equity for 3 consecutive years, with 0.35% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 5.0% to 0.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.35% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.45% for FY2025, 4.0% down from the prior year.
  • Return on Equity hit 0.35% in Q4 2025 for Compass Therapeutics, up from 0.46% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.28% in Q4 2023 to a low of 0.65% in Q2 2025.
  • Historically, Return on Equity has averaged 0.4% across 3 years, with a median of 0.35% in 2025.
  • Biggest YoY gain for Return on Equity was 5bps in 2025; the steepest drop was -34bps in 2025.
  • Year by year, Return on Equity stood at 0.28% in 2023, then plummeted by -45bps to 0.4% in 2024, then grew by 12bps to 0.35% in 2025.
  • Business Quant data shows Return on Equity for CMPX at 0.35% in Q4 2025, 0.46% in Q3 2025, and 0.65% in Q2 2025.